Novavax
NVAX
#5616
Rank
C$1.76 B
Marketcap
C$10.76
Share price
-0.56%
Change (1 day)
16.54%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): C$0.66 Billion

According to Novavax's latest financial reports the company's current earnings are C$1.08 Billion. , an increase over its 2024 earnings that were of -C$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 C$0.63 B-396.87%
2024 -C$0.22 Billion-70.39%
2023 -C$0.72 Billion-16.59%
2022 -C$0.87 Billion-62.58%
2021 -C$2.31 Billion320.54%
2020 -C$0.55 Billion234.22%
2019 -C$0.17 Billion-30.17%
2018 -C$0.24 Billion1.69%
2017 -C$0.24 Billion-36.44%
2016 -C$0.37 Billion70.4%
2015 -C$0.22 Billion89.27%
2014 -C$0.12 Billion59.83%
2013 -C$70.36 Million81.9%
2012 -C$38.68 Million50.33%
2011 -C$25.73 Million
2009 -C$50.78 Million8.8%
2008 -C$46.67 Million18.01%
2007 -C$39.55 Million18.33%
2006 -C$33.42 Million168.31%
2005 -C$12.46 Million-62.51%
2004 -C$33.23 Million52.4%
2003 -C$21.81 Million-28.21%
2002 -C$30.37 Million
2000 -C$17.31 Million177%
1999 -C$6.25 Million-11.54%
1998 -C$7.07 Million10.64%
1997 -C$6.39 Million-9.62%
1996 -C$7.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.20 B 3,418.72%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$13.84 B 2,093.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$19.16 B 2,935.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$13.43 B 2,029.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-C$0.96 Billion-251.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.4 Billion-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$28.06 M-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-C$11.04 Million-101.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$0.36 B-42.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.22 B-64.43%๐Ÿ‡บ๐Ÿ‡ธ USA